Recombinant GH replacement in hypopituitary adults improves endothelial cell function and reduces calculated absolute and relative coronary risk.
about
Role of growth hormone, insulin-like growth factor 1 and insulin-like growth factor-binding protein 3 in development of non-alcoholic fatty liver diseaseOne-year GH replacement therapy reduces early cardiac target organ damage (TOD) in adult GHD patients.GH replacement reduces increased lipid peroxidation in GH-deficient adults.Peripheral fibrinolytic markers, soluble adhesion molecules, inflammatory cytokines and endothelial function in hypopituitary adults with growth hormone deficiency.Dipeptidyl Peptidase-4 Inhibition Potentiates Stimulated Growth Hormone Secretion and Vasodilation in Women.
P2860
Recombinant GH replacement in hypopituitary adults improves endothelial cell function and reduces calculated absolute and relative coronary risk.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Recombinant GH replacement in ...... te and relative coronary risk.
@en
Recombinant GH replacement in ...... te and relative coronary risk.
@nl
type
label
Recombinant GH replacement in ...... te and relative coronary risk.
@en
Recombinant GH replacement in ...... te and relative coronary risk.
@nl
prefLabel
Recombinant GH replacement in ...... te and relative coronary risk.
@en
Recombinant GH replacement in ...... te and relative coronary risk.
@nl
P2093
P2860
P1476
Recombinant GH replacement in ...... te and relative coronary risk.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2265.2004.02109.X
P577
2004-09-01T00:00:00Z